BUB: Permanent FDA authorisation enables expansion in the US infant formula market and contract manufacturing
Permanent FDA authorisation for goat, grass-fed, and essential infant formula products positions the company as a key non-US supplier in the US market. This milestone enables expansion into high-growth segments and contract manufacturing, supporting long-term profitable growth.Original document: Bu…